Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
333
-
Total 13F shares, excl. options
-
60.1M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$9.7B
-
Value change
-
+$262M
-
Put/Call ratio
-
0.81
-
Number of buys
-
178
-
Number of sells
-
-147
-
Price
-
$161.51
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2018
414 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2018.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 333 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.1M shares
of 106M outstanding shares and own 56.87% of the company stock.
Largest 10 shareholders include FMR LLC (9.89M shares), Vanguard Group Inc (5.38M shares), BlackRock Inc. (4.81M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.08M shares), SANDS CAPITAL MANAGEMENT, LLC (1.9M shares), FIL Ltd (1.79M shares), FRED ALGER MANAGEMENT INC (1.58M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.3M shares), STATE STREET CORP (1.23M shares), and JENNISON ASSOCIATES LLC (1.22M shares).
This table shows the top 333 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.